A Synthetic-biology Approach to Understanding Bacterial Programmed Death and Implications for Antibiotic Treatment

Loading...
Thumbnail Image

Date

2013

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

748
views
586
downloads

Abstract

Programmed death is often associated with a bacterial stress response. This behavior appears paradoxical, as it offers no benefit to the individual. This paradox can be explained if the death is `altruistic': the sacrifice of some cells can benefit the survivors through release of `public goods'. However, the conditions where bacterial programmed death becomes advantageous have not been unambiguously demonstrated experimentally. Here, I determined such conditions by engineering tunable, stress-induced altruistic death in the bacterium Escherichia coli. Using a mathematical model, we predicted the existence of an optimal programmed death rate that maximizes population growth under stress. I further predicted that altruistic death could generate the `Eagle effect', a counter-intuitive phenomenon where bacteria appear to grow better when treated with higher antibiotic concentrations. In support of these modeling insights, I experimentally demonstrated both the optimality in programmed death rate and the Eagle effect using our engineered system. These findings fill a critical conceptual gap in the analysis of the evolution of bacterial programmed death, and have implications for a design of antibiotic treatment.

Description

Provenance

Citation

Citation

Tanouchi, Yu (2013). A Synthetic-biology Approach to Understanding Bacterial Programmed Death and Implications for Antibiotic Treatment. Dissertation, Duke University. Retrieved from https://hdl.handle.net/10161/7116.

Collections


Except where otherwise noted, student scholarship that was shared on DukeSpace after 2009 is made available to the public under a Creative Commons Attribution / Non-commercial / No derivatives (CC-BY-NC-ND) license. All rights in student work shared on DukeSpace before 2009 remain with the author and/or their designee, whose permission may be required for reuse.